Jianqin Li

Suzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Correction: Correlation between the CD8+ T cell/IFN-γ axis and clinical disease progression at different phases of ITP.

Correction: Correlation between the CD8+ T cell/IFN-γ axis and clinical disease progression at different phases of ITP.

Journal: Frontiers in pediatrics

Published: August 11, 2026

Correlation between the CD8+ T cell/IFN-γ axis and clinical disease progression at different phases of ITP.

Correlation between the CD8+ T cell/IFN-γ axis and clinical disease progression at different phases of ITP.

Journal: Frontiers in pediatrics

Published: June 10, 2026

BRD4 regulation of PIM1 identifies a novel therapeutic vulnerability in acute megakaryoblastic leukemia.

BRD4 regulation of PIM1 identifies a novel therapeutic vulnerability in acute megakaryoblastic leukemia.

Journal: Cancer cell international

Published: August 09, 2025

USP20, a Super-enhancer Regulated Gene, Promotes Acute Myeloid Leukemia Progression through CTNNB1 Deubiquitination.

USP20, a Super-enhancer Regulated Gene, Promotes Acute Myeloid Leukemia Progression through CTNNB1 Deubiquitination.

Journal: International journal of biological sciences

Published: August 01, 2025

No increased risk of hepatic enzyme abnormalities with non-peptidic thrombopoietin receptor agonists in immune thrombocytopenia: A meta-analysis of randomized controlled trials.

No increased risk of hepatic enzyme abnormalities with non-peptidic thrombopoietin receptor agonists in immune thrombocytopenia: A meta-analysis of randomized controlled trials.

Journal: Experimental and therapeutic medicine

Published: July 17, 2025

Thrombopoietin receptor agonists use and risk of thrombotic events in patients with immune thrombocytopenic purpura: A systematic review and meta‑analysis of randomized controlled trials.

Thrombopoietin receptor agonists use and risk of thrombotic events in patients with immune thrombocytopenic purpura: A systematic review and meta‑analysis of randomized controlled trials.

Journal: Biomedical reports

Published: September 24, 2023

Safety of non‑peptide thrombopoietin receptor agonists in patients with immune thrombocytopenia: A systematic review and meta‑analysis of short‑term double‑blind randomized clinical trials.

Safety of non‑peptide thrombopoietin receptor agonists in patients with immune thrombocytopenia: A systematic review and meta‑analysis of short‑term double‑blind randomized clinical trials.

Journal: Experimental and therapeutic medicine

Published: February 22, 2023

Effect of BCG HSP70 Gene Transfection on Dendritic Cells Derived From Bone Marrow in Children With Acute Leukemia.

Effect of BCG HSP70 Gene Transfection on Dendritic Cells Derived From Bone Marrow in Children With Acute Leukemia.

Journal: Journal of pediatric hematology/oncology

Published: September 02, 2021

Correction: Extracellular vesicles derived from miR-199a-5p-modified adipose-derived mesenchymal stem cells alleviate immune thrombocytopenia by inhibiting T helper 17 differentiation.

Correction: Extracellular vesicles derived from miR-199a-5p-modified adipose-derived mesenchymal stem cells alleviate immune thrombocytopenia by inhibiting T helper 17 differentiation.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: May 19, 2021

HUWE1 Causes an Immune Imbalance in Immune Thrombocytopenic Purpura by Reducing the Number and Function of Treg Cells Through the Ubiquitination Degradation of Ets-1.

HUWE1 Causes an Immune Imbalance in Immune Thrombocytopenic Purpura by Reducing the Number and Function of Treg Cells Through the Ubiquitination Degradation of Ets-1.

Journal: Frontiers in cell and developmental biology

Published: May 12, 2021

High Expression of Interleukin-3 Receptor Alpha Chain (CD123) Predicts Favorable Outcome in Pediatric B-Cell Acute Lymphoblastic Leukemia Lacking Prognosis-Defining Genomic Aberrations.

High Expression of Interleukin-3 Receptor Alpha Chain (CD123) Predicts Favorable Outcome in Pediatric B-Cell Acute Lymphoblastic Leukemia Lacking Prognosis-Defining Genomic Aberrations.

Journal: Frontiers in oncology

Published: October 06, 2020

Minimally myelosuppressive regimen for remission induction in pediatric AML: long-term results of an observational study.

Minimally myelosuppressive regimen for remission induction in pediatric AML: long-term results of an observational study.

Journal: Blood advances

Published: September 21, 2020

Showing 1-12 of 15

Last Updated: 09/26/2026